Alembic Pharmaceuticals receives US FDA approval for Doxorubicin Hydrochloride Liposome injection EP News Bureau Jun 30, 2025 Alembic secures final US FDA approval for generic version of Doxil Liposome Injection used in ovarian cancer, AIDS-related…
